‘Struggle’ between France and Germany over vaccines: a brand new scandal in Europe

Berlin accuses Paris of getting pressured the European Fee to purchase thousands and thousands of doses of the French Sanofi vaccine, which might solely be prepared on the finish of the 12 months.

The European Fee has agreements with numerous pharmaceutical firms to provide the 27 member states of the European Union with nearly 2 billion doses of their coronavirus vaccines. Amongst these pharmaceutical firms, a number of German firms take part: Curevac and BioNTech (with Pfizer), the French Sanofi, the American Moderna and others corresponding to AstraZeneca (with the College of Oxford) or Jansen.

The anger over the alleged lack of vaccines, which for now doesn’t appear actual as a result of no nation within the European Union managed to prick not half the vials acquired within the first two remittances, climbed one level when France was accused from Germany of getting pressured the European Fee to purchase the identical quantity of French vaccines (Sanofi) than German (BioNTech and Curevac). Paris denied it the identical Tuesday by way of the mouth of its Secretary of State for European Affairs, Clément Beaune, who mentioned they have been “false and unacceptable” accusations.

Paris felt singled out as a result of that concept is rising in Germany after a report within the weekly ‘Der Spiegel’ printed in December. In it, the German journal mentioned that the European Fee might have commissioned as much as 500 million doses of the Pfizer / BioNTech vaccine and initially solely ordered 300 million “as a result of Paris protected Sanofi”.

The Pfizer / BioNTech vaccine has been on the forefront of its growth for months, and Sanofi’s is lagging behind, which might imply it will not be out there till the European summer season. Or, based on the newest data, till the tip of the 12 months.

Sanofi introduced in mid-December that it ought to delay the event of its vaccine (which it does along with the British GSK) as a result of it must do a second examine. The delay is as a result of the primary product he developed solely exhibits efficient safety in adults between 18 and 49 years outdated. These over 50 years outdated confirmed “a low immune response.”

The Sanofi vaccine It is conventional and it’s primarily based on the expertise of frequent flu vaccines developed by the pharmaceutical firm itself. Traces of the virus are injected into the affected person to generate an immune response and be ready for when contaminated. Sanofi additionally works, along with the American TranslateBio on a messenger RNA-based vaccine, the mannequin utilized by Moderna and Pfizer / BioNTech, however it’s nonetheless within the first section of trials.

Karl Lauterbach, spokesman for the German Social Democrats on Well being and a specialist in Well being Economics, assured that “France insisted that the variety of vaccines (from Pfizer / BioNTech) was not a lot larger than that of Sanofi, even supposing that vaccine was removed from prepared ”.

The European Fee introduced on Monday that it’s negotiating with Pfizer / BioNTech extending your order in one other 200 million doses to rise up to 500 million. From the opposite German, Curevac, he requested 400 million doses. In accordance with the French Secretary of State, this exhibits that “the German laboratories should not being handled worse” as a result of they have been charged with “Greater than Sanofi”. The French the European Fee had ordered 300 million doses.

Beaune took the chance to cost towards these in Germany who ask the Merkel authorities, along with ready for the doses which are coming from the contracts signed by the European Fee (on Tuesday he had punctured simply over 300,000 doses of round 1.3 million acquired), additionally purchase by yourself. In accordance with the Secretary of State of the Macron authorities: “Remoted methods are tempting within the quick time period however ineffective over time.”

Brussels, particular

ap

.

trending

Related Articles